CN105602856A - 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 - Google Patents
黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 Download PDFInfo
- Publication number
- CN105602856A CN105602856A CN201510945197.0A CN201510945197A CN105602856A CN 105602856 A CN105602856 A CN 105602856A CN 201510945197 A CN201510945197 A CN 201510945197A CN 105602856 A CN105602856 A CN 105602856A
- Authority
- CN
- China
- Prior art keywords
- lovastatin
- fermentation
- bacterial strain
- strain
- aspergillus niger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 title claims abstract description 62
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 title claims abstract description 62
- 229960004844 lovastatin Drugs 0.000 title claims abstract description 62
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 title claims abstract description 62
- 238000000855 fermentation Methods 0.000 title claims abstract description 46
- 230000004151 fermentation Effects 0.000 title claims abstract description 46
- 241000228245 Aspergillus niger Species 0.000 title claims abstract description 37
- 238000004519 manufacturing process Methods 0.000 title abstract description 13
- 238000004321 preservation Methods 0.000 claims abstract description 8
- 230000001580 bacterial effect Effects 0.000 claims description 58
- 239000001963 growth medium Substances 0.000 claims description 19
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000002609 medium Substances 0.000 claims description 12
- 239000007836 KH2PO4 Substances 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 9
- 238000011218 seed culture Methods 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 238000012546 transfer Methods 0.000 claims description 7
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Inorganic materials [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- 239000012531 culture fluid Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 claims description 5
- 235000015278 beef Nutrition 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 3
- 239000011686 zinc sulphate Substances 0.000 claims description 3
- 235000015895 biscuits Nutrition 0.000 claims description 2
- 238000011534 incubation Methods 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 230000000877 morphologic effect Effects 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 5
- 238000005457 optimization Methods 0.000 abstract description 3
- 244000005700 microbiome Species 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 108020004463 18S ribosomal RNA Proteins 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 238000012300 Sequence Analysis Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 241000228212 Aspergillus Species 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000012530 fluid Substances 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000012797 qualification Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 241000345998 Calamus manan Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005374 membrane filtration Methods 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241001465318 Aspergillus terreus Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000003810 ethyl acetate extraction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 108091005508 Acid proteases Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000009599 head growth Effects 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- -1 pectase Proteins 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/66—Aspergillus
- C12R2001/685—Aspergillus niger
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510945197.0A CN105602856B (zh) | 2015-12-16 | 2015-12-16 | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510945197.0A CN105602856B (zh) | 2015-12-16 | 2015-12-16 | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105602856A true CN105602856A (zh) | 2016-05-25 |
CN105602856B CN105602856B (zh) | 2019-04-16 |
Family
ID=55983205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510945197.0A Active CN105602856B (zh) | 2015-12-16 | 2015-12-16 | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105602856B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108004279A (zh) * | 2016-11-01 | 2018-05-08 | 北大方正集团有限公司 | 用于提高洛伐他汀发酵水平的发酵培养基及补料方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0556699A1 (en) * | 1992-02-10 | 1993-08-25 | Novopharm Ltd. | Novel fungal strains and use thereof in antibiotic production |
CN101928701A (zh) * | 2009-06-23 | 2010-12-29 | 华东理工大学 | 提高真菌产酶和次级代谢物的方法 |
CN104561166A (zh) * | 2014-12-01 | 2015-04-29 | 山东中惠食品有限公司 | 一种高产洛伐他汀的生产方法 |
-
2015
- 2015-12-16 CN CN201510945197.0A patent/CN105602856B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0556699A1 (en) * | 1992-02-10 | 1993-08-25 | Novopharm Ltd. | Novel fungal strains and use thereof in antibiotic production |
CN101928701A (zh) * | 2009-06-23 | 2010-12-29 | 华东理工大学 | 提高真菌产酶和次级代谢物的方法 |
CN104561166A (zh) * | 2014-12-01 | 2015-04-29 | 山东中惠食品有限公司 | 一种高产洛伐他汀的生产方法 |
Non-Patent Citations (4)
Title |
---|
J.L. CASAS LÓPEZ A,ET AL.: "Production of lovastatin by Aspergillus terreus: effects of the C:N ratio and the principal nutrients on growth and metabolite production", 《ENZYME AND MICROBIAL TECHNOLOGY》 * |
RAGHUNATH R,ET AL.: "PRODUCTION AND CYTOTOXICITY STUDIES OF LOVASTATIN FROM Aspergillus niger PN2 AN ENDOPHYTIC FUNGI ISOLATED FROM Taxus baccata", 《INTERNATIONAL JOURNAL OF APPLIED BIOLOGY AND PHARMACEUTICAL TECHNOLOGY》 * |
SADIA JAVED,ET AL.: "Screening of Indigenously Isolated Fungi for Lovastin Production and its in vivo Evaluation", 《CURRENT PHARMACEUTICAL BIOTECHNOLOGY》 * |
SYARIFAH ABDUL RASHID,ET AL.: "EFFECT OF CULTURAL CONDITIONS ON LOVASTATIN PRODUCTION BY ASPERGILLUS NIGER SAR I USING COMBINATION OF RICE BRAN AND BROWN RICE AS SUBSTRATE", 《INTERNATIONAL JOURNAL OF APPLIED BIOLOGY AND PHARMACEUTICAL TECHNOLOGY》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108004279A (zh) * | 2016-11-01 | 2018-05-08 | 北大方正集团有限公司 | 用于提高洛伐他汀发酵水平的发酵培养基及补料方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105602856B (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11242502B2 (en) | Low urea-producing and flavor-producing Wickerhamomyces anomalus strain and use thereof in food production | |
CN103025862B (zh) | 新型破囊壶菌类微藻及用其生产生物油的方法 | |
CN106978350A (zh) | 一株黑曲霉及其在普洱茶素类化合物的制备中的应用 | |
CN104893989B (zh) | 小孢根霉须状变种zjph1308及在制备西他列汀中间体中的应用 | |
CN107177519A (zh) | 粟酒裂殖酵母菌、其组合物和应用 | |
CN102703339B (zh) | 高产精氨酸脱亚胺酶菌株及用它生产l-瓜氨酸的方法 | |
CN106047713B (zh) | 一株嗜松篮状菌菌株Li-93及其应用 | |
CN102972211A (zh) | 一种提高灵芝菌丝生长速度和液体发酵生物量的方法 | |
CN102827777B (zh) | 海绵共附生土曲霉及制备(+)-terrein的用途 | |
CN105219653B (zh) | 产洛伐他汀的棒曲霉(Aspergillus clavatus)Ac-32菌株及其应用 | |
CN102766663B (zh) | 桑黄活性多糖的制备方法 | |
CN104277985A (zh) | 红曲霉(Monascus purpureus)M-24菌株及其用于Monacolin K制备中应用 | |
CN104611236B (zh) | 刺孢小克银汉霉FAR3及其发酵制备γ-亚麻酸油脂的方法 | |
CN106754430A (zh) | 高产洛伐他汀枝状枝孢菌Cc‑106菌株及其用途 | |
CN105602917A (zh) | 一种橙皮苷酶的生产方法及应用 | |
CN102021212A (zh) | 一种灵芝多糖的制备方法 | |
CN106479900B (zh) | 高产洛伐他汀草酸青霉Po-25菌株及其用途 | |
CN101487022A (zh) | 抑制肝癌细胞生长的发酵液的制备方法 | |
CN105602856A (zh) | 黑曲霉(Aspergillus niger)An-19菌株及其用于洛伐他汀的生产的用途和发酵方法 | |
CN108949595A (zh) | 一种产香酵母菌及其在红曲黄酒酿造中的应用 | |
CN1141377C (zh) | 高海藻糖含量的酿酒酵母及其生产方法 | |
CN104862238B (zh) | 一株酿酒酵母及其应用 | |
CN112094762B (zh) | 一株葡萄牙棒孢酵母菌株及其应用 | |
CN101008000A (zh) | 一种生产β-胡萝卜素的粘性红圆酵母、β-胡萝卜素及其生产方法 | |
CN103865804B (zh) | β-葡萄糖苷酶高产菌及其在转化制备白藜芦醇中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240130 Address after: Room 2920, Building B, No. 9 Hisense Tianchen Road, Jinan City, Shandong Province, 250000 Patentee after: Zhuofan (Jinan) Technology Innovation Co.,Ltd. Country or region after: China Address before: 321004 No. 688 Yingbin Road, Zhejiang, Jinhua Patentee before: ZHEJIANG NORMAL University Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240206 Address after: 710100 Building 6, No. 381 Kunchi 1st Road, Xiliu Street Office, High tech Zone, Xi'an City, Shaanxi Province Patentee after: Shaanxi Didu Pharmaceutical and Chemical Co.,Ltd. Country or region after: China Address before: Room 2920, Building B, No. 9 Hisense Tianchen Road, Jinan City, Shandong Province, 250000 Patentee before: Zhuofan (Jinan) Technology Innovation Co.,Ltd. Country or region before: China |